Fda Alerts Article Listing | RxWiki

FDA Alerts

FDA Approves New Multiple Sclerosis Drug

The US Food and Drug Administration approved Aubagio (teriflunomide), a once-a-day tablet for the treatment of adults with relapsing forms of multiple sclerosis (MS).

REFINE

medications
- - Remove Aubagio filter (-) Remove Aubagio filter Aubagio
conditions
- - Apply Neuromuscular Disease filter Neuromuscular Disease (1) Apply Neuromuscular Disease filter
    Apply Multiple Sclerosis filter Multiple Sclerosis (1) Apply Multiple Sclerosis filter